NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO)
INR 15.17
(0.46%)
INR 15.17
(0.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 26.38 Million INR | 211.22% |
| 2022 | 8.47 Million INR | -60.9% |
| 2021 | 21.68 Million INR | -9.56% |
| 2020 | 23.97 Million INR | 198.4% |
| 2019 | 8.03 Million INR | 1035.65% |
| 2018 | -858.83 Thousand INR | 58.97% |
| 2017 | -2.09 Million INR | -244.79% |
| 2016 | -607.16 Thousand INR | -136.0% |
| 2015 | 1.68 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 11.48 Million INR | 256.36% |
| 2023 Q4 | 3.22 Million INR | -72.17% |
| 2023 Q1 | 9.46 Million INR | 1333.94% |
| 2023 FY | 26.38 Million INR | 211.22% |
| 2023 Q2 | 2.11 Million INR | -77.65% |
| 2023 Q3 | 11.58 Million INR | 447.71% |
| 2022 Q2 | -3000.00 INR | -100.05% |
| 2022 FY | 8.47 Million INR | -60.9% |
| 2022 Q4 | 660 Thousand INR | -63.5% |
| 2022 Q3 | 1.8 Million INR | 60366.67% |
| 2022 Q1 | 6.35 Million INR | 90814.29% |
| 2021 Q1 | 1.45 Million INR | 148.96% |
| 2021 Q4 | -7000.00 INR | -100.04% |
| 2021 FY | 21.68 Million INR | -9.56% |
| 2021 Q3 | 17.1 Million INR | 753.74% |
| 2021 Q2 | 2 Million INR | 37.35% |
| 2020 FY | 23.97 Million INR | 198.4% |
| 2020 Q4 | -2.98 Million INR | 0.0% |
| 2019 FY | 8.03 Million INR | 1035.65% |
| 2018 FY | -858.83 Thousand INR | 58.97% |
| 2017 FY | -2.09 Million INR | -244.79% |
| 2016 FY | -607.16 Thousand INR | -136.0% |
| 2015 FY | 1.68 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 142.31 Million INR | 81.458% |
| Checkpoint Trends Limited | 11.3 Million INR | -133.323% |
| Everest Organics Limited | 426.16 Million INR | 93.808% |
| GUJARAT INJECT (KERALA) LTD. | 3.85 Million INR | -584.826% |
| NATURO INDIABULL LIMITED | 21.45 Million INR | -22.995% |
| Rajnish Wellness Limited | 56.65 Million INR | 53.423% |
| Rama Vision Limited | 272.22 Million INR | 90.307% |
| Vivo Bio Tech Limited | 416.01 Million INR | 93.657% |